In an era of increasing rates of drug resistant tuberculosis and lack of fully effective medicines, the role of surgery in management of tuberculosis is being revisited. In 2012-2013, WHO Regional Office for Europe hosted an international Task Force who developed an expert opinion paper based on the available evidence. In order to discuss further and exchange opinion, GHDonline is pleased to welcome a panel composed of the following experts (in alphabetic order):
• Paul Bolinowski, Thoracic surgeon, New Jersey, USA
• Dmitriy Giller, Thoracic surgeon, Moscow, Russian Federation
• Igor Kalabukha, Thoracic surgeon, Kiev, Ukraine
• Ravindra Kdewan, Thoracic surgeon, New Delhi, India
• Denis Krasnov, Thoracic surgeon, Novosibirsk, Russian Federation
• Alfred Lardizabal MD, New Jersey, USA
• Giovanni Sotgiu MD and Public Health expert, Sassari, Italy
• Jean-Pierre Zellweger MD, Bern, Switzerland
Moderated by: Masoud Dara MD, Brussels, Belgium
During our week-long discussion from 12 to 16 January 2015, the panelists will address the following questions:
1. Which patients and at which stage of their disease would benefit most from surgical interventions?
2. What are the risk/benefits of surgical interventions and how to mitigate them?
3. How to combine medical and surgical treatment?
4. Which types of surgical interventions are recommended?
5. What are the requirements for a successful outcome of a surgical operation?
6. How to build further the evidence for rational use of surgery?
We’re looking forward to a rich discussion the week of 12 January 2015 week – please join the conversation and share your questions and/or comments with the panelists!